Pharmaceutical supply chain supply chain chokepoints

category tradeable chokepoint

How scores are shown

Criticality comes from the trace model and describes the node's dependency importance.

Evidence comes from the canonical Vein Graph: AI assertions, user corrections, and external sources.

Completeness is a data-coverage label based on available summary, evidence, sources, tickers, and chokepoint rationale.

Dynamic claims are capped below 100% and AI-only edges remain labeled as inferred. Model: trace-score-v1.

⚠ Hidden chokepoints found

API manufacturing (India / China)90% confidence — A large share of generic APIs is sourced from a handful of Asian sites; inspections can halt batches.

KSM & precursor chemicals90% confidence — Single-source KSMs create fragility during pollution crackdowns or export licensing.

Sterile fill-finish capacity90% confidence — Fill-finish slots are scarce; pandemic-era bottlenecks persist for new launches.

Pharmaceutical supply chainHealthcare

Active pharmaceutical ingredients through formulation and sterile fill-finish.

Criticality: unknownEvidence: UnverifiedCompleteness: thin

API manufacturing (India / China)Manufacturing⚠ chokepoint

Bulk synthesis of small-molecule APIs and intermediates.

A large share of generic APIs is sourced from a handful of Asian sites; inspections can halt batches.90% confidence

DRREDDY—Dr. Reddy'sstock

ProducerSupplies into this nodeSupply-chain context only — not investment advice.

Criticality: highEvidence: UnverifiedCompleteness: partial

KSM & precursor chemicalsChemicals⚠ chokepoint

Key starting materials for antibiotics, analgesics, and oncology APIs.

Single-source KSMs create fragility during pollution crackdowns or export licensing.90% confidence

Criticality: highEvidence: UnverifiedCompleteness: partial

— core tradeable element

Sterile fill-finish capacityCDMO⚠ chokepoint

Vials, syringes, and lyophilization for injectable drugs.

Fill-finish slots are scarce; pandemic-era bottlenecks persist for new launches.90% confidence

Criticality: highEvidence: UnverifiedCompleteness: partial

— core tradeable element

Cold chain logisticsLogisticsmedium criticality

2–8°C and ultra-cold distribution for biologics and vaccines.

Criticality: mediumEvidence: UnverifiedCompleteness: thin

— core tradeable element

Excipients & glass vialsMaterialsmedium criticality

Borosilicate vials, stoppers, and stabilizer excipients.

Criticality: mediumEvidence: UnverifiedCompleteness: thin

— core tradeable element

Sector templates

Generated analysis — not investment advice.

Loading page…